Compare Bandhan Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.44
2.19
NAV
₹10.23
₹44.45
Fund Started
10 Nov 2025
25 Jun 2018
Fund Size
₹290.55 Cr
₹6668.95 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
-
5.68%
3 Year
-
26.25%
5 Year
-
15.27%
Equity
95.88%
96.76%
Cash
4.09%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.34% |
Apollo Hospitals Enterprise Ltd. | 8.67% |
Divi's Laboratories Ltd. | 7.61% |
Max Healthcare Institute Ltd. | 6.92% |
Cipla Ltd. | 6.76% |
Dr. Reddy's Laboratories Ltd. | 5.92% |
JB Chemicals & Pharmaceuticals Ltd. | 4.57% |
Mankind Pharma Ltd. | 3.48% |
Ajanta Pharma Ltd. | 2.91% |
Aurobindo Pharma Ltd. | 2.87% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 Nov 2025
25 Jun 2018
